{
    "abstractText": "Phthalide, benzoxazole, and chromene are important heterocyclic skeletons with extensive biological activities. In order to develop novel potential antifungal agents, twenty-two benzoxazole/chromene-containing phthalide derivatives were prepared, and their fungicidal activity against nine common plants pathogenic fungi were evaluated in vitro. The EC50 values indicated that compound Z-4b displayed superior antifungal activity against P. oryzae (11.0 \u03bcg/mL), F. solani (8.5 \u03bcg/mL), P. capsici (27.8 \u03bcg/mL), V. mali (3.1 \u03bcg/mL) and A. brassicae (4.3 \u03bcg/mL) strains, which was more potent than the two commercialized fungicides hymexazol and chlorothalonil. In addition, the structure-activity relationship analysis demonstrated that the combination site of oxazolamide with phthalide has an important effect on antifungal activity. This research offers a potential compound for the development of novel agricultural fungicides.",
    "authors": [
        {
            "affiliations": [],
            "name": "Yong Li"
        },
        {
            "affiliations": [],
            "name": "Zhongfu Luo"
        },
        {
            "affiliations": [],
            "name": "Akang Zhou"
        },
        {
            "affiliations": [],
            "name": "Wenjing Liu"
        },
        {
            "affiliations": [],
            "name": "Judi Fan"
        },
        {
            "affiliations": [],
            "name": "Jing Miao"
        },
        {
            "affiliations": [],
            "name": "Bing Guo"
        },
        {
            "affiliations": [],
            "name": "Lei Tang"
        },
        {
            "affiliations": [],
            "name": "Lingling Fan"
        },
        {
            "affiliations": [],
            "name": "Xuan Voli"
        }
    ],
    "id": "SP:8117f3a9897ae94c46541af8e22caad9da815785",
    "references": [],
    "sections": [
        {
            "text": "Phthalide, benzoxazole, and chromene are important heterocyclic skeletons with extensive biological activities. In order to develop novel potential antifungal agents, twenty-two benzoxazole/chromene-containing phthalide derivatives were prepared, and their fungicidal activity against nine common plants pathogenic fungi were evaluated in vitro. The EC50 values indicated that compound Z-4b displayed superior antifungal activity against P. oryzae (11.0 \u03bcg/mL), F. solani (8.5 \u03bcg/mL), P. capsici (27.8 \u03bcg/mL), V. mali (3.1 \u03bcg/mL) and A. brassicae (4.3 \u03bcg/mL) strains, which was more potent than the two commercialized fungicides hymexazol and chlorothalonil. In addition, the structure-activity relationship analysis demonstrated that the combination site of oxazolamide with phthalide has an important effect on antifungal activity. This research offers a potential compound for the development of novel agricultural fungicides.\nKEY WORDS: Phthalide derivatives; benzoxazol; chromene; antifungal activity; phytopathogenic fungi\nContents\n1. Experimental\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026....................... P1"
        },
        {
            "heading": "2. Spectroscopic Data\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.............. P4",
            "text": "3. Table S1. Antifungal activity of the tested compounds at 50 \u03bcg/mL in vitro\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.............. P9\n4. Table S2. EC50 (\u03bcg/mL) values of compound Z-4b against seven phytopathogenic fungi\u2026\u2026\u2026\u2026\u2026\u2026......... P9 5. Figure S1. Design strategy of the target compounds\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026.\u2026\u2026.. P10\n6. Figure S2. The synthetic route of target compounds 2a-d\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026... P10\n7. Figure S3. The synthetic route of target compounds Z-4a-c\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026... P10\n8. Figure S4. The synthetic route of target compounds E-4a-d and 5a-f\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026...P11\n9. Figure S5. Effects of compound Z-4b on the growth of seven phytopathogenic fungi at different concentrations\n(CK: blank control group)\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..... P11\n10. Figure S6. Compound Z-4b docked to the active pocket of Sec14p by molecular docking\u2026\u2026\u2026\u2026\u2026\u2026\u2026P12 11. 1H-NMR, 13C-NMR and HRMS Spectra of the target compounds (Figure S7-S67)\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026P13"
        },
        {
            "heading": "1. Experimental",
            "text": ""
        },
        {
            "heading": "1.1. General information",
            "text": "All reagents were purchased from commercial sources. Melting points were detected on a\nWRS-1B digital melting-point apparatus (Suzhou Xuan Voli Intelligent Technology Co., Ltd). NMR spectra were obtained on Bruker Avance NEO 400, or 600 MHz instruments, using TMS as the internal standard, CDCl3, DMSO-d6, or CD3CN as the solvent. HRMS were recorded using APEX II Bruker 4.7T AS instrument."
        },
        {
            "heading": "1.2. General procedure for the synthesis of target compounds",
            "text": "3-butyl-6-(2-methylbut-3-yn-2-yloxy)isobenzofuran-1(3H)-one (2a): To a solution of compound 1 (0.6 g, 2.9 mmol), K2CO3 (1.1 g, 8.2 mmol) and NaI (108.3 mg, 0.72 mmol) in acetone/H2O (10 mL/2 mL), and 3-chloro-3-methylbutyne (0.8 g, 8.2 mmol) was added. The reaction mixture was stirred at 60 o C for 12 h. After completing, the solvent was removed under reduced pressure and the residue was purified by column chromatography to give the compound 2a (504.8 mg, 64.0%) as a colorless oil. 3-butyl-6-(2-methylbut-3-en-2-yloxy)isobenzofuran-1(3H)-one (2b): Compound 2a (300 mg, 1.1 mmol) and Lindlar catalyst (30%, 116.2 mg) were dissolved in hexane (15 mL), and the reaction mixture was stirred at 30 o C for 1 h under hydrogen atmosphere. After completing, the reaction mixture was filtered and the solvent was evaporated in vacuo. The residue was purified by column chromatography to give the compound 2b (298.4 mg, 99.0%) as a colorless oil. 3-butyl-6-hydroxy-7-(3-methylbut-2-en-1-yl)isobenzofuran-1(3H)-one (2c): Compound 2b (274 mg, 1.0 mmol) was dissolved in N-methyl-2-pyrrolidone (NMP, 5 mL), the mixture was stirred at 90 o C for 24 h under argon atmosphere until the reaction was completed. Next, H2O (15 mL) was added and the mixture was extracted with EtOAc (3 \u00d7 20 mL). The combined organic was dried over Na2SO4, concentrated in vacuo, and purified by column chromatography to give the compound 2c (139.7 mg, 51.0%) as a white solid. 3-butyl-7,7-dimethyl-3,7-dihydro-1H-furo[3,4-f]chromen-1-one (2d): To a solution of compound 2a (82.2 mg, 0.3\u202fmmol) in dry pyridine (2 mL), after stirring at 120\u202f\u00b0C for 8 h, the reaction mixture was adjusted pH = 4 with 2N HCl, which was extracted with EtOAc (20 mL \u00d72), dried over anhydrous Na2SO4, evaporated and purified with column chromatography to obtain compound 3d (62.7 mg, 76.8%) as a colorless oil.\n3-butyl-6-hydroxy-5-nitroisobenzofuran-1(3H)-one (Z-1): To a solution of compound 1 (3.87 g, 12.66 mmol) in acetic acid (5 mL) and DCM (10 mL), 48% nitric acid (5 mL) was added dropwise slowly at 0 \u00b0C under a nitrogen atmosphere, the reaction mixture was stirred at 25 \u00b0C for 1 h. Next, H2O (15 mL) was added to the mixture and extracted with DCM (30 mL \u00d7 3), the combined organic layers were washed with brine, dried over anhydrous Na2SO4, and evaporated in vacuo. The crude residue was purified by column chromatography to give the compound Z-1 (2.15 g, 67.6%) as a white solid. 5-amino-3-butyl-6-hydroxyisobenzofuran-1(3H)-one (Z-2): To a solution of Z-1 (400 mg, 1.59 mmol) in EtOH (5 mL), SnCl2 (1.8 g, 7.96 mmol) was added. The mixture was stirred at 80 o C for 12h under a nitrogen atmosphere (monitored by TLC). Subsequently, the solution was removed under vacuum and adjusted to pH = 7-8 with saturated NaHCO3, which was then extracted with DCM (30 mL \u00d7 3), dried over anhydrous Na2SO4, and concentrated in vacuo. The crude product was purified by column chromatography to give the compound Z-2 (267.4 mg, 76.1%) as a white solid. 2-amino-5-butylisobenzofuro[5,6-d]oxazol-7(5H)-one (Z-3): To a solution of compound Z-2 (216.6 mg, 0.98 mmol) in CH3OH (4 mL) and H2O (2 mL), cyanide bromide (BrCN, 154.7 mg, 1.46 mmol) was added dropwise. The reaction mixture was stirred at 65 o C for 5 h under the nitrogen atmosphere, and then adjusted to pH = 7-8 with saturated NaHCO3, the mixture was extracted with EtOAc (30 mL \u00d7 3), dried over anhydrous Na2SO4, and evaporated in vacuo. The crude residue was purified by silica gel column chromatography to give the compound Z-3 (177.4 mg, 73.6%) as a white solid. 3-butyl-6-hydroxy-7-nitroisobenzofuran-1(3H)-one (E-1): To a solution of compound 1 (3.3 g, 15.9 mmol) and potassium nitrate (2.1 g, 20.6 mmol) in H2SO4 (15 mL) at 0 o C. The reaction mixture was stirred at 25 o C for 3h and then ice water was added, the mixture was extracted with EtOAc (50 mL \u00d7 3), dried over anhydrous Na2SO4, evaporated under reduced pressure, and purified by column chromatography to give the compound E-1 (3.3 g, 83.4%) as a yellow solid. 7-amino-3-butyl-6-hydroxyisobenzofuran-1(3H)-one (E-2): To a solution of E-1 (2.4 g, 9.56 mmol) and iron powder (2.3 g, 41.3 mmol) in CH3OH (5 mL) and H2O (5 mL). The reaction was refluxed for 8h under an argon atmosphere. Then the reaction mixture was filtered and the residue was washed with ethanol, combined filtrate was concentrated under vacuum and purified by column\nchromatography to obtain the compound E-2 (1.57 g, 74.3%) as a white solid. 2-amino-6-butylisobenzofuro[4,5-d]oxazol-8(6H)-one (E-3): To a solution of E-2 (1.1 g, 4.97 mmol) and dicyandiamide (1.25 g, 1.49 mmol) in anhydrous THF (5 mL), FeCl3 (2.42 g, 1.49 mmol) in anhydrous THF (5 mL) was added at 0 o C. Then the reaction was heated at 60\u00b0C under N2 until completion (TLC monitoring, 48 h). The reaction solvent was evaporated under reduced pressure and the residue was purified by column chromatography to afford the desired product E-3 (448.7 mg, 36.7%) as a white solid. General synthesis procedure for compounds Z-4a-c and E-4a-e\nTo a solution of Z-3 or E-3 (30.0 mg, 0.12 mmol) in dried pyridine (0.5 mL), substituted acyl\nchloride (0.24 mmol) was added slowly at 0 o C. The reaction mixture was stirred at room temperature until the starting material disappearance (monitored by TLC). The reaction mixture was adjusted to pH = 3-4 with 2N HCl and extracted with DCM (10 mL \u00d7 3). The organic phase was dried over anhydrous Na2SO4, filtered, evaporated, and purified by column chromatography to give the compounds Z-4a-c and E-4a-e. General synthesis procedure for compounds 5a-f\nA suspension of E-2 (114 mg, 0.52 mmol), substituted benzaldehyde (0.57 mmol) and cupric\nacetate monohydrate (10 mg, 0.052 mmol) in toluene (4 mL), the reaction mixture was stirred at 90 o C under a nitrogen atmosphere until completion (TLC monitoring). Then the reaction mixture was concentrated, and purified by column chromatography to afford the compounds 5a-f."
        },
        {
            "heading": "1.3. Antifungal assay",
            "text": "The antifungal activities were determined by the mycelium growth rate method, and the\nSPSS 21.0 (SPSS Inc., Chicago, USA) software was used for data analysis. [Li Y, Luo ZF, Luo BL, Lan Q, Fan JD, Xue W, Miao J, Li Y, Tang L, Fan LL. 2020. Design, synthesis and antifungal activities of 6-substituted n-butyphthalide derivatives against phytopathogenic fungi. Chem Biodiversity. 17(10): e2000435.]"
        },
        {
            "heading": "1.4. Molecular docking studies",
            "text": "The crystal structure of the lipid transfer protein sec14p (Saccharomyces cerevisiae) was\nobtained from the Brookhaven protein data bank (PDB 6F0E; http://www.rcsb.org/pdb). The molecular docking studies were performed with SYBYL-X 2.0 software according to the previously reported method. [Fan LL, Luo ZF, Yang CF, Tang L, Li Y. 2022. Design and\nsynthesis of small molecular 2-aminobenzoxazoles as potential antifungal agents against phytopathogenic fungi. Mol Divers. 26: 981-992]"
        },
        {
            "heading": "2. Spectroscopic Data",
            "text": "3-butyl-6-(2-methylbut-3-yn-2-yloxy)isobenzofuran-1(3H)-one (2a): yield = 64.0 %, colourless oil; 1 H NMR (600 MHz, CDCl3) \u03b4 7.75 (d, J = 1.8 Hz, 1H), 7.43 (dd, J = 8.4, 2.4 Hz, 1H), 7.32 (d, J = 7.8 Hz, 1H), 5.43-5.41 (m, 1H), 2.63 (s, 1H), 2.02-1.98 (m, 1H), 1.76-1.71 (m, 1H), 1.68 (s, 6H), 1.48-1.35 (m, 4H), 0.92 (t, J = 7.2 Hz, 3H); 13\nC NMR (150 MHz, CDCl3) \u03b4 170.5, 156.4, 144.2,\n128.0, 127.0, 122.2, 116.4, 85.0, 81.2, 75.0, 73.1, 34.5, 29.4, 26.9, 22.4, 13.8; HRMS (ESI) calcd for C17H21O3 + [M+H] + m/z: 273.1491, found 273.1487. 3-butyl-6-(2-methylbut-3-en-2-yloxy)isobenzofuran-1(3H)-one (2b): yield = 99.0 %, colourless oil; 1 H NMR (400 MHz, CDCl3) \u03b4 7.44 (d, J = 1.2 Hz, 1H), 7.26-7.25 (m, 2H), 6.14-6.07 (m, 1H), 5.40-5.37 (m, 1H), 5.23-5.18 (m, 2H), 2.01-1.94 (m, 1H), 1.76-1.70 (m, 1H), 1.48 (s, 6H), 1.42-1.35 (m, 4H), 0.92 (t, J = 7.2 Hz, 3H); 13\nC NMR (100 MHz, CDCl3) \u03b4 170.7, 157.0, 143.6, 143.2, 128.2,\n126.8, 122.1, 116.3, 114.6, 81.3, 80.5, 34.6, 26.98, 26.94, 22.4, 13.8. HRMS (ESI) calcd for C17H23O3 + [M+H] + m/z: 275.1647, found 275.1643. 3-butyl-6-hydroxy-7-(3-methylbut-2-en-1-yl)isobenzofuran-1(3H)-one (2c): yield = 51.0 %, white solid, m.p. 140-142 \u00b0C; 1 H NMR (600 MHz, CDCl3) \u03b4 7.12 (s, 2H), 5.90 (s, 1H), 5.31-5.26 (m, 2H), 3.97 (d, J = 0.6 Hz, 2H), 1.99-1.94 (m, 1H), 1.84 (s, 3H), 1.77 (s, 3H), 1.71-1.65 (m, 1H), 1.47-1.33 (m, 4H), 0.91 (t, J = 7.2 Hz, 3H); 13\nC NMR (150 MHz, CDCl3) \u03b4 170.8, 155.8, 142.9, 136.3, 126.7,\n123.9, 122.3, 120.5, 120.0, 79.8, 34.7, 26.8, 25.8, 23.3, 22.4, 18.0, 13.8. HRMS (ESI) calcd for C17H23O3 + [M+H] + m/z: 275.1647, found 275.1646. 3-butyl-7,7-dimethyl-3,7-dihydro-1H-furo[3,4-f]chromen-1-one (2d): yield = 76.8 %, colourless oil; 1 H NMR (600 MHz, CDCl3) \u03b4 7.33 (d, J = 10.2 Hz, 1H), 7.09 (d, J = 7.8 Hz, 1H), 7.02 (d, J = 7.8 Hz, 1H), 5.80 (d, J = 10.2 Hz, 1H), 5.34-5.32 (m, 1H), 2.00-1.94 (m, 1H), 1.74-1.67 (m, 1H), 1.46 (s, 3H), 1.45 (s, 3H), 1.43-1.34 (m, 4H), 0.91 (t, J = 7.2 Hz, 3H); 13\nC NMR (150 MHz, CDCl3) \u03b4 170.5,\n153.3, 142.7, 133.6, 122.3, 121.0, 120.5, 119.6, 117.1, 80.6, 76.9, 34.6, 28.0, 27.9, 26.8, 22.4, 13.8; HRMS (ESI) calcd for C17H21O3 + [M+H] + m/z: 273.1491, found 273.1494. 3-butyl-6-hydroxy-5-nitroisobenzofuran-1(3H)-one (Z-1): yield = 67.6 %, white solid, m.p. 158-159 \u00b0C; 1 H NMR (400 MHz, CDCl3) \u03b4 10.6 (s, 1H, OH), 8.21 (s, 1H), 7.68 (s, 1H), 5.52-5.49 (m, 1H), 2.08-2.03 (m, 1H), 1.80-1.76 (m, 1H), 1.50-1.36 (m, 4H), 0.94 (t, J = 6.8 Hz, 3H, CH3);\n13 C NMR (100 MHz, CDCl3) \u03b4 167.8, 155.5, 139.4, 136.9, 133.6, 118.9, 117.2, 81.2, 34.5, 26.7, 22.3, 13.8; HRMS (ESI) calcd for C12H14NO5 + [M+H] + m/z: 252.0872, found 252.0866. 5-amino-3-butyl-6-hydroxyisobenzofuran-1(3H)-one (Z-2): yield = 76.1 %, white solid, m.p. 193-194 \u00b0C; 1 H NMR (600 MHz, DMSO-d6) \u03b4 9.82 (s, 1H), 6.89 (s, 1H), 6.60 (s, 1H), 5.69 (s, 2H, NH2), 5.29-5.27 (m, 1H), 1.88-1.84 (m, 1H), 1.58-1.54 (m, 1H), 1.31-1.24 (m, 4H), 0.87 (t, J = 6.6 Hz, 3H); 13\nC NMR (150 MHz, DMSO-d6) \u03b4 170.9, 145.0, 144.9, 144.8, 112.1, 107.9, 104.3, 79.9,\n34.5, 26.7, 22.4, 14.3; HRMS (ESI) calcd for C12H16NO3 + [M+H] + m/z: 222.1130, found 222.1136. 2-amino-5-butylisobenzofuro[5,6-d]oxazol-7(5H)-one (Z-3): yield = 73.6 %, white solid, m.p. 194-196 \u00b0C; 1 H NMR (600 MHz, DMSO-d6) \u03b4 7.99 (s, 2H), 7.69 (s, 1H), 7.36 (s, 1H), 5.54-5.53 (m, 1H), 2.10-2.05 (m, 1H), 1.70-1.65 (m, 1H), 1.35-1.23 (m, 4H), 0.87 (t, J = 7.2 Hz, 3H); 13 C NMR (150 MHz, DMSO-d6) \u03b4 170.6, 165.9, 151.1, 148.9, 147.8, 117.2, 108.2, 104.6, 80.9, 34.3, 26.7, 22.3, 14.2; HRMS (ESI) calcd for C13H15N2O3 + [M+H] + m/z: 247.1083, found 247.1086. 3-butyl-6-hydroxy-7-nitroisobenzofuran-1(3H)-one (E-1): yield = 83.4%, yellow solid, m.p. 156-157 \u00b0C; 1 H NMR (400 MHz, CDCl3) \u03b4 9.79 (s, 1H, OH), 7.57 (d, J = 8.4 Hz, 1H), 7.51 (d, J = 8.4 Hz, 1H), 5.39-5.36 (m, 1H), 2.06-2.02 (m, 1H), 1.74-1.72 (m, 1H), 1.48-1.38 (m, 4H), 0.93 (t, J = 6.8 Hz, 3H, CH3); 13 C NMR (100 MHz, CDCl3) \u03b4 164.0, 154.4, 145.1, 131.4, 128.1, 126.8, 120.6, 79.3, 34.1, 26.7, 22.3, 13.8; HRMS (ESI) calcd for C12H14NO5 + [M+H] + m/z: 252.0872, found 252.0875. 7-amino-3-butyl-6-hydroxyisobenzofuran-1(3H)-one (E-2): yield = 74.3%, white solid, m.p. 214-217 \u00b0C; 1 H NMR (600 MHz, DMSO-d6) \u03b4 9.56 (s, 1H), 6.93 (d, J = 7.8 Hz, 1H), 6.49 (dd, J = 7.8, 1.6 Hz, 1H), 5.60 (s, 2H, NH2), 5.37-5.35 (m, 1H), 1.93-1.87 (m, 1H), 1.63-1.57 (m, 1H), 1.35-1.24 (m, 4H), 0.87 (t, J = 7.2 Hz, 3H); 13\nC NMR (150 MHz, DMSO-d6) \u03b4 171.7, 143.5, 141.0,\n137.0, 120.0, 108.1, 108.0, 80.7, 34.7, 26.7, 22.3, 14.3; HRMS (ESI) calcd for C12H16NO3 + [M+H] + m/z: 222.1130, found 222.1137. 2-amino-6-butylisobenzofuro[4,5-d]oxazol-8(6H)-one (E-3): yield = 36.7%, white solid, m.p. 248-249 \u00b0C; 1 H NMR (600 MHz, DMSO-d6) \u03b4 7.97 (s, 2H), 7.68 (d, J = 8.4 Hz, 1H), 7.11 (d, J = 7.8 Hz, 1H), 5.56 -5.55 (m, 1H), 2.06-2.01 (m, 1H), 1.71-1.65 (m, 1H), 1.36-1.22 (m, 4H), 0.87 (t, J = 7.2 Hz, 3H); 13\nC NMR (150 MHz, DMSO-d6) \u03b4 168.4, 166.0, 149.2, 146.7, 142.2, 114.0, 112.6,\n112.0, 81.0, 34.5, 26.7, 22.3, 14.2; HRMS (ESI) calcd for C13H15N2O3 + [M+H] + m/z: 247.1083, found 247.1082.\nN-(5-butyl-7-oxo-5,7-dihydroisobenzofuro[5,6-d]oxazol-2-yl)-4-fluorobenzamide (Z-4a): yield = 34.9%, white solid, m.p. 238-240 o C; 1 H NMR (400 MHz, CD3CN) \u03b4 8.21-8.18 (m, 2H), 7.58 (s, 1H), 7.34 (s, 1H), 7.16-7.11 (m, 2H), 5.44-5.39 (m, 1H), 1.97-1.96 (m, 1H), 1.75 -1.57 (m, 1H), 1.46-1.25 (m, 4H), 0.89 (t, J = 6.8 Hz, 3H); 13\nC NMR (100 MHz, CD3CN) \u03b4 176.1, 159.2, 146.6,\n134.9, 131.4, 131.3, 114.8, 114.6, 114.5, 114.3, 113.1, 109.5, 107.9, 103.8, 81.2, 34.3, 26.7, 22.1, 13.2; HRMS (ESI) calcd for C20H18N2O4F + [M+H] + m/z: 369.1251, found 369.1246. N-(5-butyl-7-oxo-5,7-dihydroisobenzofuro[5,6-d]oxazol-2-yl)-4-chlorobenzamide (Z-4b): yield = 63.4%, white solid, m.p. 246-249 o C; 1 H NMR (600 MHz, DMSO-d6) \u03b4 12.49 (s, 1H), 8.15-8.01 (m, 3H), 7.86 (s, 1H), 7.64 (d, J = 7.8 Hz, 2H), 5.68-5.67 (m, 1H), 2.16-2.12 (m, 1H), 1.76-1.71 (m, 1H), 1.39-1.26 (m, 4H), 0.89 (t, J = 7.2 Hz, 3H); 13\nC NMR (150 MHz, DMSO-d6) \u03b4 170.0,\n147.7, 138.3, 138.2, 131.0, 129.1, 121.1, 107.0, 81.2, 34.2, 26.8, 22.3, 14.2; HRMS (ESI) calcd for C20H18N2O4Cl + [M+H] + m/z: 385.0955, found 385.0957. N-(5-butyl-7-oxo-5,7-dihydroisobenzofuro[5,6-d]oxazol-2-yl)hexanamide (Z-4c): yield = 9.5%, white solid, m.p. 215-217 o C; 1 H NMR (600 MHz, DMSO-d6) \u03b4 8.02 (s, 1H), 7.79 (s, 1H), 5.67-5.65 (m, 1H), 2.52-2.48 (m, 2H), 2.15-2.11 (m, 1H), 1.75-1.70 (m, 1H), 162-1.60 (m, 2H), 1.34-1.23 (m, 8H), 0.89-0.85 (m, 6H); 13\nC NMR (150 MHz, DMSO-d6) \u03b4 170.8, 169.6, 159.2,\n157.9, 147.7, 147.0, 120.2, 111.3, 106.2, 80.7, 39.7, 35.8, 33.6, 30.5, 26.1, 23.8, 21.77, 21.75, 13.7; HRMS (ESI) calcd for C19H25N2O4 + [M+H] + m/z: 345.1814, found 345.1820. N-(6-butyl-8-oxo-6,8-dihydroisobenzofuro[4,5-d]oxaz-ol-2-yl)-4-fluorobenzamide (E-4a): yield = 31.1%, white solid, m.p. 183-186 o C; 1 H NMR (600 MHz, DMSO-d6) \u03b4 12.59 (s, 1H), 8.15-8.13 (m, 2H), 8.10 (d, J = 8.4 Hz, 1H), 7.54 (d, J = 8.4 Hz, 1H), 7.43 (t, J = 8.4 Hz, 2H), 5.71-5.69 (m, 1H), 2.16-2.11 (m, 1H), 1.77-1.73 (m, 1H), 1.36-1.26 (m, 4H), 0.88 (t, J = 7.2 Hz, 3H); 13 C NMR (150 MHz, DMSO-d6) \u03b4 167.9, 166.1, 164.5, 159.1, 149.2, 148.4, 131.9, 129.5, 117.1, 116.5, 116.2, 116.1, 115.0, 81.5, 34.2, 26.8, 22.3, 14.2. HRMS (ESI) calcd for C20H18N2O4F + [M+H] + m/z: 369.1251, found 369.1253. N-(6-butyl-8-oxo-6,8-dihydroisobenzofuro[4,5-d]oxa-zol-2-yl)-4-chlorobenzamide (E-4b): yield = 36.5%, white solid, m.p. 209-216 o C; 1 H NMR (600 MHz, DMSO-d6) \u03b4 12.64 (s, 1H), 8.10 (d, J = 8.4 Hz, 1H), 8.08 (d, J = 9.0 Hz, 2H), 7.66 (d, J = 8.4 Hz, 2H), 7.54 (d, J = 8.4 Hz, 1H), 5.71-5.69 (m, 1H), 2.16-2.10 (m, 1H), 1.77-1.71 (m, 1H), 1.41-1.26 (m, 4H), 0.88 (t, J = 7.2 Hz, 3H); 13 C NMR (150 MHz, DMSO-d6) \u03b4 167.9, 164.1, 159.0, 149.2, 148.5, 138.3, 137.9, 131.8, 130.8, 129.2,\n117.2, 116.5, 115.0, 81.6, 34.2, 26.8, 22.3, 14.2. HRMS (ESI) calcd for C20H18N2O4Cl + [M+H] + m/z: 385.0955, found 385.0954. N-(6-butyl-8-oxo-6,8-dihydroisobenzofuro[4,5-d]oxaz-ol-2-yl)-2-ethoxybenzamide (E-4c): yield = 52.3%, white solid, m.p. 162-167 o C; 1 H NMR (600 MHz, DMSO-d6) \u03b4 11.99 (s, 1H), 8.07 (d, J = 8.4 Hz, 1H), 7.67 (dd, J = 7.8, 1.2 Hz, 1H), 7.57-7.54 (m, 1H), 7.52 (d, J = 8.4 Hz, 1H), 7.19 (d, J = 8.4 Hz, 1H), 7.10 (t, J = 7.2 Hz, 1H), 5.70-5.69 (m, 1H), 4.18 (q, J = 7.2 Hz, 2H), 2.15-2.10 (m, 1H), 1.77-1.71 (m, 1H), 1.36-1.25 (m, 7H), 0.88 (t, J = 7.2 Hz, 3H); 13 C NMR (150 MHz, DMSO-d6) \u03b4 167.9, 164.3, 158.4, 156.7, 149.1, 148.4, 138.2, 133.8, 130.5, 123.5, 120.9, 117.1, 116.4, 115.0, 113.5, 81.5, 64.7, 34.2, 26.8, 22.3, 14.9, 14.2\uff1bHRMS (ESI) calcd for C22H23N2O5 + [M+H] + m/z: 395.1607, found 395.1610. N-(6-butyl-8-oxo-6,8-dihydroisobenzofuro[4,5-d]oxazol-2-yl)hexanamide (E-4d): yield = 41.9%, white solid, m.p. 190-192 o C; 1 H NMR (400 MHz, DMSO-d6) \u03b4 12.03 (s, 1H), 8.03 (d, J = 8.4 Hz, 1H), 7.48 (d, J = 8.2 Hz, 1H), 5.68-5.65 (m, 1H), 2.50-2.48 (m, 2H), 2.13-2.07 (m, 1H), 1.76-1.59 (m, 3H), 1.35-1.22 (m, 8H), 0.89-0.84 (m, 6H); 13\nC NMR (150 MHz, DMSO-d6) \u03b4 171.3, 167.9,\n158.6, 149.0, 148.2, 138.2, 116.7, 116.2, 114.8, 81.4, 36.4, 34.2, 31.1, 26.8, 24.4, 22.34, 22.31, 14.28, 14.27; HRMS (ESI) calcd for C19H25N2O4 + [M+H] + m/z: 345.1814, found 345.1813. 6-butyl-2-phenylisobenzofuro[4,5-d]oxazol-8(6H)-one (5a): yield = 50.1%, white solid, m.p. 137-138 o C; 1 H NMR (600 MHz, CDCl3) \u03b4 8.39 (d, J = 6.6 Hz, 2H), 7.89 (d, J = 8.4 Hz, 1H), 7.60-7.53 (m, 3H), 7.37 (d, J = 8.4 Hz, 1H), 5.60-5.58 (m, 1H), 2.14-2.10 (m, 1H), 1.83-1.77 (m, 1H), 1.54-1.34 (m, 4H), 0.92 (t, J = 7.2 Hz, 3H); 13\nC NMR (150 MHz, CDCl3) \u03b4 168.2, 166.3,\n151.7, 148.1, 139.4, 132.4, 128.9, 128.4, 126.2, 117.3, 117.1, 116.1, 81.5, 34.7, 26.8, 22.4, 13.8; HRMS (ESI) calcd for C19H18NO3 + [M+H] + m/z: 308.1287, found 308.1289. 6-butyl-2-(4-fluorophenyl)isobenzofuro[4,5-d]oxazol-8(6H)-one (5b): yield=10.5%; white solid; m.p. 192-193 o C; 1 H NMR (600 MHz, CDCl3) \u03b4 8.40-8.38 (m, 2H), 7.88 (d, J = 7.8 Hz, 1H), 7.37 (d, J = 8.4 Hz, 1H), 7.25-7.22 (m, 2H), 5.60-5.58 (m, 1H), 2.14-2.09 (m, 1H), 1.81-1.77 (m, 1H), 1.51-1.33 (m, 4H), 0.92 (t, J = 7.2 Hz, 3H); 13\nC NMR (150 MHz, DMSO-d6) \u03b4 168.8, 165.9, 152.8,\n150.2, 139.5, 132.0, 124.0, 120.3, 118.5, 118.4, 118.2, 117.5, 82.7, 35.1, 27.9, 23.3, 15.3. HRMS (ESI) calcd for C19H17NO3F + [M+H] + m/z: 326.1192, found 326.1191. 2-(2-bromophenyl)-6-butylisobenzofuro[4,5-d]oxazol-8(6H)-one (5c): yield = 9.8%, white solid, m.p. 101-102 o C; 1 H NMR (600 MHz, CDCl3) \u03b4 8.26 (dd, J = 7.8, 1.8 Hz, 1H), 7.95 (d, J = 8.4 Hz,\n1H), 7.78 (dd, J = 7.8, 1.2 Hz, 1H), 7.50-7.47 (m, 1H), 7.42-7.39 (m, 2H), 5.61-5.59 (m, 1H), 2.15-2.10 (m, 1H), 1.85-1.78 (m, 1H), 1.52-1.35 (m, 4H), 0.92 (t, J = 7.2 Hz, 3H); 13 C NMR (150 MHz, DMSO-d6) \u03b4 167.9, 164.1, 159.0, 155.1, 149.2, 148.5, 138.3, 137.9, 131.8, 130.8, 129.2, 117.2, 116.5, 115.0, 81.6, 34.2, 26.8, 22.3, 14.2. HRMS (ESI) calcd for C19H17NO3Br + [M+H] + m/z: 386.0392, found 386.0388. 6-butyl-2-(4-hydroxyphenyl)isobenzofuro[4,5-d]oxazol8-(6H)-one (5d): yield = 16.0%, white solid, m.p. 237-238 o C; 1 H NMR (600 MHz, DMSO-d6) \u03b4 10.48 (s, 1H), 8.15 (d, J = 8.4 Hz, 1H), 8.12 (d, J = 8.4 Hz, 2H), 7.60 (d, J = 8.4 Hz, 1H), 7.01 (d, J = 8.4 Hz, 2H), 5.72-5.70 (m, 1H), 2.16-2.11 (m, 1H), 1.77-1.71 (m, 1H), 1.40-.26 (m, 4H), 0.88 (t, J = 7.2 Hz, 3H); 13 C NMR (150 MHz, DMSO-d6) \u03b4 167.9, 166.2, 162.1, 151.5, 148.7, 139.0, 130.4, 118.3, 117.0, 116.9, 116.7, 115.8, 81.5, 34.2, 26.9, 22.3, 14.2; HRMS (ESI) calcd for C19H18NO4 + [M+H] + m/z: 324.1236, found 324.1232. 2-(6-butyl-8-oxo-6,8-dihydroisobenzofuro[4,5-d]oxazol-2-yl)benzoic acid (5e): yield = 16.3%, white solid, m.p. 92-93 o C; 1 H NMR (600 MHz, DMSO-d6) \u03b4 8.22 (d, J = 8.4 Hz, 1H), 8.01-8.00 (m, 1H), 7.96-7.95 (m, 1H), 7.82-7.78 (m, 2H), 7.72 (d, J = 8.4 Hz, 1H), 5.77-5.75 (m, 1H), 2.19-2.13 (m, 1H), 1.80-1.74 (m, 1H), 1.39-1.27 (m, 4H), 0.89 (t, J = 7.2 Hz, 3H); HRMS (ESI) calcd for C20H18NO5 + [M+H] + m/z: 352.1185, found 352.1175. 6-butyl-2-(4-(diphenylamino)phenyl)isobenzofuro-[4,5-d]oxazol-8(6H)-one (5f): yield = 42.4%, white solid, m.p. 163-164 o C; 1 H NMR (600 MHz, DMSO-d6) \u03b4 8.14 (d, J = 8.4 Hz, 1H), 8.09 (d, J = 9.0 Hz, 2H), 7.60 (d, J = 8.4 Hz, 1H), 7.44-7.41 (m, 4H), 7.23-7.20 (m, 6H), 7.01 (d, J = 9.0 Hz, 2H), 5.71-5.69 (m, 1H), 2.13-2.11 (m, 1H), 1.76-1.72 (m, 1H), 1.39-1.27 (m, 4H), 0.88 (t, J = 7.2 Hz, 3H); 13\nC NMR (150 MHz, DMSO-d6) \u03b4 167.9, 165.9, 151.6, 151.5, 148.7, 146.2, 139.0, 130.4,\n129.7, 126.6, 125.6, 119.8, 118.3, 117.5, 117.0, 115.8, 81.5, 34.2, 26.9, 22.3, 14.2. HRMS (ESI) calcd for C31H27N2O3 + [M+H] + m/z: 475.2022, found 475.2019.\nTable S1. Antifungal activity of the tested compounds at 50\u03bcg/mL in vitro\nCompd. Inhibition rate \u00b1 SD (%) (n = 3)\nA. alternariae P. oryzae P. capsici F. oxysporum F. solani S. sclerotiorum V. mali A. brassicae F. graminearum\n1 51.4\u00b11.2 25.5\u00b10.6 27.0\u00b11.3 28.5\u00b12.4 27.8\u00b10.4 47.4\u00b12.2 54.2\u00b10.9 31.2\u00b12.7 16.7\u00b11.8 2a 44.9\u00b11.7 36.1\u00b11.2 30.8\u00b11.1 12.2\u00b10.7 - 55.2\u00b12.9 54.9\u00b12.3 43.5\u00b10.1 48.1\u00b12.1 2b 43.5\u00b10.2 45.5\u00b12.2 0.5\u00b10.9 5.6\u00b11.5 39.6\u00b11.7 31.7\u00b11.8 32.8\u00b11.9 41.3\u00b12.0 47.9\u00b12.2 2c 51.7\u00b12.4 41.9\u00b11.7 43.5\u00b12.7 29.3\u00b11.2 55.9\u00b12.8 52.4\u00b12.3 43.0\u00b11.1 54.4\u00b12.1 21.5\u00b11.2 2d 24.5\u00b11.3 11.1\u00b10.8 20.5\u00b10.4 - 10.1\u00b11.2 6.9\u00b10.3 18.3\u00b10.1 8.7\u00b10.5 7.4\u00b11.5 Z-2 41.7\u00b11.4 27.5\u00b10.6 2.5\u00b10.3 7.7\u00b11.2 28.9\u00b11.6 23.1\u00b12.2 13.1\u00b10.9 42.6\u00b14.8 18.6\u00b11.8 E-2 82.6\u00b11.8 30.8\u00b12.4 25.4\u00b10.8 18.4\u00b10.6 22.2\u00b12.7 25.0\u00b12.5 16.7\u00b10.8 22.9\u00b11.5 22.7\u00b11.8 Z-3 12.5\u00b1 2.5 10.6\u00b10.2 17.6\u00b14.4 13.5\u00b11.2 2.2\u00b11.4 - 8.2\u00b10.9 34.2\u00b11.6 45.8\u00b13.8 E-3 54.3\u00b11.0 48.7\u00b11.2 31.7\u00b10.6 22.4\u00b11.7 56.5\u00b13.8 47.5\u00b11.5 30.0\u00b10.4 43.8\u00b12.6 45.5\u00b12.3 Z-4a 80.3\u00b10.8 70.5\u00b15.4 72.5\u00b12.3 53.4\u00b12.4 65.5\u00b10.9 52.4\u00b11.1 70.9\u00b10.6 58.9\u00b11.5 43.1\u00b11.3 Z-4b 87.5\u00b10.5 82.5\u00b10.6 70.6\u00b11.3 86.5\u00b11.2 93.3\u00b11.6 38.5\u00b10.8 70.5\u00b10.9 72.3\u00b11.5 74.6\u00b13.8 Z-4c 66.7\u00b11.4 62.5\u00b10.3 41.2\u00b11.3 51.9\u00b11.2 68.9\u00b10.4 56.4 \u00b12.2 62.3\u00b10.1 55.3\u00b11.0 66.1\u00b11.5 E-4a 51.0\u00b12.1 41.7\u00b11.3 30.8\u00b11.1 51.2\u00b12.4 37.5\u00b11.5 37.9\u00b11.1 60.6\u00b12.8 43.5\u00b12.1 44.4\u00b11.2 E-4b 40.8\u00b11.3 25.5\u00b12.5 41.0\u00b12.0 51.2\u00b12.9 35.0\u00b11.9 34.5\u00b11.5 50.6\u00b12.6 23.9\u00b11.1 44.4\u00b11.4 E-4c 36.7\u00b11.4 13.9\u00b10.3 - 31.7\u00b11.4 17.5\u00b10.8 58.6\u00b13.0 9.9\u00b10.8 26.1\u00b11.8 1.9\u00b13.1 E-4d 20.4\u00b10.1 8.3\u00b11.5 0.5\u00b11.2 36.6\u00b11.7 15.9\u00b11.7 24.1\u00b11.6 19.7\u00b11.4 8.7\u00b11.5 25.9\u00b11.9\n5a 2.1\u00b12.2 - - 15.4\u00b11.2 11.1\u00b11.4 10.3\u00b11.3 14.8\u00b10.7 8.5\u00b11.5 - 5b 14.6\u00b11.4 7.5\u00b10.8 - 9.6\u00b12.2 37.8\u00b10.9 28.2\u00b12.0 3.3\u00b10.9 10.6\u00b11.1 25.4\u00b11.0 5c 31.3\u00b12.0 20.3\u00b11.3 7.8\u00b11.9 21.2\u00b11.4 44.4\u00b12.9 43.6\u00b11.1 36.1\u00b10.9 29.8\u00b11.0 39.3\u00b11.0 5d 2.7\u00b12.5 9.5\u00b10.9 - 7.7\u00b12.9 26.7\u00b11.5 8.3\u00b10.7 13.1\u00b13.3 12.8\u00b11.5 25.4\u00b13.8 5e 1.1\u00b11.1 5.1\u00b11.4 2.0\u00b10.9 9.6\u00b11.2 15.6\u00b11.3 5.1\u00b11.6 - 17.2\u00b11.5 5.1\u00b11.0 5f 8.3\u00b11.3 5.2\u00b11.3 - 1.9\u00b11.8 8.9\u00b11.6 7.7\u00b11.1 1.6\u00b12.4 12.8\u00b11.5 22.2\u00b13.8 NBP 42.2\u00b10.6 37.8\u00b11.3 35.4\u00b11.0 43.5\u00b11.2 61.2\u00b12.1 55.2\u00b12.3 44.8\u00b12.3 28.6\u00b10.8 60.2\u00b10.7 Hym 79.2\u00b10.4 62.5\u00b12.5 29.7\u00b10.9 50.4\u00b10.7 45.6\u00b11.5 75.5\u00b12.1 30.0\u00b11.5 76.6\u00b11.6 55.7\u00b11.0\nChl 56.3\u00b11.4 51.2\u00b11.8 48.6\u00b11.3 65.0\u00b11.2 70.1\u00b11.6 80.0\u00b10.5 71.2\u00b10.7 38.3\u00b11.3 71.4\u00b11.0\nNBP: Butylphthalide; Hym: Hymexazol; Chl: Chlorothalonil;\nTable S2. EC50 (\u03bcg/mL) values of compound Z-4b against seven phytopathogenic fungi\nCompounds EC50 (95% CI) / (\u00b5g/mL)\nA. alternariae P. oryzae P. capsici F. oxysporum F. solani V. mali A. brassicae F. graminearum\nZ-4b 22.5\n(19.0-27.1)\n11.0\n(4.4-23.7)\n27.8\n(21.9-37.8)\n26.1\n(14.3-97.9)\n8.5\n(6.8-24.3)\n3.1\n(1.0-4.9)\n4.3\n(1.7-6.6)\n29.8\n(17.2-117.1)\nHym 10.9\n(9.0-13.0)\n18.2\n(15.7-21.2) >50\n57.2\n(37.0-122.1) >50 >50\n17.3\n(6.1-192.4)\n22.1\n(17.8-28.7)\nChl 20.8\n(10.2-36.0)\n37.1\n(16.0-62.1) >50\n8.8\n(5.9-13.1)\n13.1\n(6.1-38.5)\n8.9\n(5.4-14.8) >50\n2.9\n(0.5-5.7)\n50% Effective concentration (EC50): concentration of compound that inhibits the fungi growth; 95% CI means 95% confidence interval of EC50; \u201c>50\u201d means the compounds with inhibition rates < 50% at 50 \u03bcg/mL;\nFigure S1. Design strategy of the target compounds\nFigure S2. The synthetic route of target compounds 2a-d\nFigure S3. The synthetic route of target compounds Z-4a-c\nFigure S4. The synthetic route of target compounds E-4a-d and 5a-f\nFigure S5. Effects of compound Z-4b on the growth of seven phytopathogenic fungi at different concentrations (CK: blank control group).\nFigure S6. Compound Z-4b docked to the active pocket of Sec14p by molecular docking.\n1 H-NMR, 13 C-NMR and HRMS of the target compounds\nFigure S7. 1H-NMR spectrum of compound 2a (CDCl3)\nFigure S8. 13C-NMR spectrum of compound 2a (CDCl3)\nFigure S9. HRMS spectrum of compound 2a\nFigure S10. 1H-NMR spectrum of compound 2b (CDCl3)\nFigure S11. 13C-NMR spectrum of compound 2b (CDCl3)\nFigure S12. HRMS spectrum of compound 2b\nFigure S13. 1H-NMR spectrum of compound 2c (CDCl3)\nFigure S14. 13C-NMR spectrum of compound 2c (CDCl3)\nFigure S15. HRMS spectrum of compound 2c\nFigure S16. 1H-NMR spectrum of compound 2d (CDCl3)\nFigure S17. 13C-NMR spectrum of compound 2d (CDCl3)\nFigure S18. HRMS spectrum of compound 2d\nFigure S19. 1H-NMR spectrum of compound Z-2 (DMSO-d6)\nFigure S20. 13C-NMR spectrum of compound Z-2 (DMSO-d6)\nFigure S21. HRMS spectrum of compound Z-2\nFigure S22. 1H-NMR spectrum of compound E-2 (DMSO-d6)\nFigure S23. 13C-NMR spectrum of compound E-2 (DMSO-d6)\nFigure S24. HRMS spectrum of compound E-2\nFigure S25. 1H-NMR spectrum of compound Z-3 (DMSO-d6)\nFigure S26. 13C-NMR spectrum of compound Z-3 (DMSO-d6)\nFigure S27. HRMS spectrum of compound Z-3\nFigure S28. 1H-NMR spectrum of compound E-3 (DMSO-d6)\nFigure S29. 13C-NMR spectrum of compound E-3 (DMSO-d6)\nFigure S30. HRMS spectrum of compound E-3\nFigure S31. 1H-NMR spectrum of compound Z-4a (CD3CN)\nFigure S32. 13C-NMR spectrum of compound Z-4a (CD3CN)\nFigure S33. HRMS spectrum of compound Z-4a\nFigure S34. 1H-NMR spectrum of compound Z-4b (DMSO-d6)\nFigure S35. 13C-NMR spectrum of compound Z-4b (DMSO-d6)\nFigure S36. HRMS spectrum of compound Z-4b\nFigure S37. 1H-NMR spectrum of compound Z-4c (DMSO-d6)\nFigure S38. 13C-NMR spectrum of compound Z-4c (DMSO-d6)\nFigure S39. HRMS spectrum of compound Z-4c\nFigure S40. 1H-NMR spectrum of compound E-4a (DMSO-d6)\nFigure S41. 13C-NMR spectrum of compound E-4a (DMSO-d6)\nFigure S42. HRMS spectrum of compound E-4a\nFigure S43. 1H-NMR spectrum of compound E-4b (DMSO-d6)\nFigure S44. 13C-NMR spectrum of compound E-4b (DMSO-d6)\nFigure S45. HRMS spectrum of compound E-4b\nFigure S46. 1H-NMR spectrum of compound E-4c (DMSO-d6)\nFigure S47. 13C-NMR spectrum of compound E-4c (DMSO-d6)\nFigure S48. HRMS spectrum of compound E-4c\nFigure S49. 1H-NMR spectrum of compound E-4d (DMSO-d6)\nFigure S50. 13C-NMR spectrum of compound E-4d (DMSO-d6)\nFigure S51. HRMS spectrum of compound E-4d\nFigure S52. 1H-NMR spectrum of compound 5a (CDCl3)\nFigure S53. 13C-NMR spectrum of compound 5a (CDCl3)\nFigure S54. HRMS spectrum of compound 5a\nFigure S55. 1H-NMR spectrum of compound 5b (CDCl3)\nFigure S56. 13C-NMR spectrum of compound 5b (CDCl3)\nFigure S57. HRMS spectrum of compound 5b\nFigure S58. 1H-NMR spectrum of compound 5c (CDCl3)\nFigure S58. 13C-NMR spectrum of compound 5c (CDCl3)\nFigure S59. HRMS spectrum of compound 5c\nFigure S60. 1H-NMR spectrum of compound 5d (DMSO-d6)\nFigure S61. 13C-NMR spectrum of compound 5d (DMSO-d6)\nFigure S62. HRMS spectrum of compound 5d\nFigure S63. 1H-NMR spectrum of compound 5e (DMSO-d6)\nFigure S64. HRMS spectrum of compound 5e\nFigure S65. 1H-NMR spectrum of compound 5f (DMSO-d6)\nFigure S66. 13C-NMR spectrum of compound 5f (DMSO-d6)\nFigure S67. HRMS spectrum of compound 5f"
        }
    ],
    "title": "Design and synthesis of novel benzoxazole/chromene-phthalide scaffolds hybrids as potential natural products-based fungicide",
    "year": 2023
}